Investments

9 Months Ended

Sep. 30, 2020

Available-for-sale investments at September 30, 2020 were as follows:


(In thousands)	Adjusted Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value

Cash equivalents:
Money market funds	$	56,855	$	—	$	—	$	56,855
Time deposits	19,676		—		—		19,676
Commercial Paper	1,600		—		—		1,600
Government and corporate bonds	1,150		—		—		1,150
Total cash equivalents	79,281		—		—		79,281

Short-term investments:
Time deposits	21,248		—		—		21,248
Commercial paper	259,000		22		(7)		259,015
Government and corporate bonds	192,536		559		(35)		193,060
Total short-term investments	472,784		581		(42)		473,323

Long-term investments:
Government and corporate bonds	91,605		180		(78)		91,707

Total available-for-sale investments	$	643,670	$	761	$	(120)	$	644,311

Available-for-sale investments at December 28, 2019 were as follows:


(In thousands)	Adjusted Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value

Cash equivalents:
Money market funds	$	185,666	$	—	$	—	$	185,666
Time deposits	64,286		—		—		64,286
Total cash equivalents	249,952		—		—		249,952

Short-term investments:
Time deposits	2,506		—		—		2,506
Government and corporate bonds	83,272		52		(11)		83,313
Total short-term investments	85,778		52		(11)		85,819

Long-term investments:
Government and corporate bonds	96,186		91		(67)		96,210

Total available-for-sale investments	$	431,916	$	143	$	(78)	$	431,981

We sold available-for-sale investments for proceeds of $5 million and $181 million during the nine months ended September 30, 2020 and September 28, 2019, respectively, resulting in insignificant gains/losses in each period.

Other Investments

At September 30, 2020 and December 28, 2019, we had investments in equity securities that do not have readily determinable fair values of $320 million and $314 million, respectively, accounted for in accordance with Accounting Standards Codification Topic ("ASC") 321, Investments-Equity Securities. Such investments are included in "Long-term investments" in our condensed consolidated balance sheets. We did not record any changes in the measurement of such investments during the nine months ended September 30, 2020 and September 28, 2019, respectively.

At June 30, 2020 and December 28, 2019, we had investments in equity securities with readily determinable fair values of $41 million and $14 million, respectively, accounted for in accordance with ASC 321. Such investments were included in "Short-term investments" in our condensed consolidated balance sheets. Changes in the measurement of such investments favorably impacted "Other income, net" by $49 million and $76 million for the three and nine months ended September 30, 2020, respectively, and $9 million for both the three and nine months ended September 28, 2019. In August 2020, we sold these investments for cash proceeds of $90 million.

At September 30, 2020 and December 28, 2019, we had investments in equity securities reported under the equity method of accounting of $11 million and $9 million, respectively. Such investments are included in "Long-term investments" in our condensed consolidated balance sheets.

Impairment Assessment

We adopted ASU 2016-13 in the first quarter of 2020, which made certain amendments to the model used to assess available-for-sale debt securities for impairment. Such guidance provides that an available-for-sale debt security is impaired if the fair value of the security is less than its amortized cost basis. A determination is made whether the decline in fair value below the amortized cost basis has resulted from a credit loss or other factors, such as market liquidity or changes in interest rates. Impairment related to credit losses is recognized in net earnings, whereas impairment related to other factors is recognized as a component of accumulated other comprehensive loss, net. During the nine months ended September 30, 2020, we did not recognize any impairment on our available-for-sale debt securities through net earnings.